The goal of QR-02 is to treat and reduce dysplasia levels, potentially offering a curative solution for oral leukoplakia, an outcome that would mark a significant breakthrough in oral medicine. By ...

Given that 80% of leukoplakia lesions occur in the oral cavity, a therapy that remains in place for an extended period is critical for success. QR-02: A Game-Changing Approach Bio-Convert’s QR ...

can lead to premalignant conditions in the oral cavity like Oral Sub Mucus Fibrosis, Leukoplakia and erythroplakia which can ...